METRIKAMIND - Development of a Digital Mental Health Ecosystem for Workplace Environments

Launched by DAVID GALLARDO-PUJOL · Oct 17, 2024

Keywords

ClinConnect Summary

The METRIKAMIND trial is focused on developing and testing a digital system aimed at improving mental health in the workplace, specifically for people dealing with depression and anxiety. The study will explore how digital tools can help detect and manage these mental health issues more effectively, and whether they can reduce the overall impact on employee productivity and well-being. Participants will use the Metrikamind platform over six months to complete mental health assessments and provide feedback on their experiences. This will help researchers understand how well the digital tools work and how they can be used to support mental health in work environments.

To participate in this study, individuals must be adults aged 18 to 70 who are currently on sick leave due to mental health issues and can use a digital device like a smartphone or computer. Those with severe psychiatric conditions or significant cognitive impairments that might interfere with their ability to engage with the platform will not be eligible. Participants can expect to share their mental health status periodically and take part in follow-up surveys to assess the long-term effects of using this digital system on their mental health and productivity at work. This trial aims to gather valuable information that could lead to better mental health strategies in workplaces.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 to 70 years.
• • Currently on sick leave due to mental health issues.
• • Has access to and is capable of using a digital device (smartphone, tablet, or computer) to interact with the Metrikamind platform.
• • Proficient in the language of the intervention and assessment tools.
• Exclusion Criteria:
• • Individuals with severe psychiatric conditions requiring inpatient care or those at high risk of suicide, which might complicate the intervention or pose a danger to the participant.
• • Significant cognitive impairments that would interfere with the participant\'s ability to comprehend or engage with the digital platform or to provide reliable self-reported data.
• • Currently participating in other clinical trials that might interfere with the outcomes of this study.
• • Lack of regular access to internet services, which are necessary for the digital intervention and data collection.